X

Today's Newsletter

Submitted by admin on Mon, 01/11/2021 - 11:16

source list reference

#7d60d9
#2694a4
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#42fc9a
#cc529a
#c59445
#c8cc0c
#e8085a
#97d1a0
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#49cde9
#c20fce
#d95d39

Today's Newsletter

Radio Updates in HER2+ GI Cancer

Submitted by adenham on Fri, 01/22/2021 - 15:53

Radio Updates in HER2+ GI Cancer

01-27-2021

Quickly catch up on the top podcasts on HER2+ GI cancer.

ASCO 2020: New Developments in the Treatment of Hard to Treat Cancers

Drs Hofland and Massacesi discuss the company’s partnerships with Daiichi Sankyo in developing a very targeted drug  for the treatment of patients with HER2+ advanced gastric cancer.

07/11/2020
Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints

This podcast discusses the JACOB trial published on pertuzumab for HER2-positive gastric cancer.

Gastric Cancer Deep Dive

This podcast briefly reviews the historical gastric cancer classifications and explains how this has drastically changed over the past 5-10 years with the advent of next-generation...

Increasing Importance of HER2 and HER3 Testing in the Context of an Expanding Targeted Therapies Landscape for Breast, Gastrointestinal, Lung, and Other Cancers

Review evidence-based guidelines and expert recommendations regarding HER2 testing and interpretation of results in breast, gastric, colorectal, non–small cell lung, and other cancers.

05/11/2020